Top-News

Momenta Pharmaceuticals News

Aktie
WKN:  A0B5Q8 ISIN:  US60877T1007 US-Symbol:  MNTA
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
117,71 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 11.05.2020

Momenta Pharmaceuticals News

25.09.20 - PR Newswire
Chesapeake Utilities to Join S&P SmallCap 600
Chesapeake Utilities to Join S&P SmallCap 600 PR Newswire
17.09.20 - PR Newswire
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm PR Newswire
26.08.20 - PR Newswire
Lifshitz Law Firm, P.C. Announces Investigation of Cancer Genetics, Inc., Jernigan Capital, Inc., Momenta Pharmaceuticals, Inc., NTN Buzztime, Inc., Principia Biopharma Inc., Spring Bank Pharmaceuticals, Inc., Varian Medical Systems, Inc., and Yintech Investment Holdings Limited
Lifshitz Law Firm, P.C. Announces Investigation of Cancer Genetics, Inc., Jernigan Capital, Inc., Momenta Pharmaceuticals, Inc., NTN Buzztime, Inc., Principia Biopharma Inc., Spring ...
22.08.20 - PR Newswire
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm - MVC, PRNB, YIN, MNTA
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm - MVC, PRNB, YIN, MNTA PR ...
20.08.20 - PR Newswire
Moore Kuehn Encourages NTN, PRNB, MNTA, and PFNX Investors to Contact Law Firm
Moore Kuehn Encourages NTN, PRNB, MNTA, and PFNX Investors to Contact Law Firm PR Newswire
19.08.20 - PR Newswire
INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Momenta Pharmaceuticals, Inc. - MNTA
INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Momenta Pharmaceuticals, Inc. - MNTA PR Newswire
19.08.20 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Investigates Momenta Pharmaceuticals, Inc.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Momenta Pharmaceuticals, Inc. PR Newswire
19.08.20 - sharedeals.de
Momenta Pharmaceuticals: Nächste Mega-Übernahme im US-Biotechsektor!
Zuletzt verging kaum ein Tag, an dem nicht irgendeine Mega-​Übernahme im US-​Biotechsektor vermeldet wurde. So auch heute. Denn heute verkündete Johnson & Johnson die ...
19.08.20 - PR Newswire
Thinking about trading options or stock in Momenta Pharmaceuticals, Regeneron Pharmaceuticals, Walmart, AbbVie Inc, or Boeing?
Thinking about trading options or stock in Momenta Pharmaceuticals, Regeneron Pharmaceuticals, Walmart, AbbVie Inc, or Boeing? PR Newswire
19.08.20 - PR Newswire
(MNTA) Alert: Johnson Fistel Investigates Proposed Sale of Momenta Pharmaceuticals; Are Shareholders Getting a Fair Price?
(MNTA) Alert: Johnson Fistel Investigates Proposed Sale of Momenta Pharmaceuticals; Are Shareholders Getting a Fair Price? PR Newswire
28.07.20 - PR Newswire
Thinking about trading options or stock in Momenta Pharmaceuticals, Xerox, Canopy Growth Corp, Apple, or Plug Power?
Thinking about trading options or stock in Momenta Pharmaceuticals, Xerox, Canopy Growth Corp, Apple, or Plug Power? PR Newswire
13.02.18 - The Motley Fool
Wird Teva Pharmaceuticals Fleiß Mylans Preis sein?
Teva Pharmaceutical (WKN:883035) berichtete diese Woche über die Ergebnisse des vierten Quartals, die einen deutlichen Rückgang der Nachfrage nach seinem meistverkauften ...
03.01.18 - PR Newswire
Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA® (aflibercept)
Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA® (aflibercept) -- Targeting the initiation of a pivotal patient clinical trial in the first half ...
12.09.17 - PR Newswire
Palatin Technologies Announces Appointment of Anthony M. Manning, Ph.D. to Board of Directors
Palatin Technologies Announces Appointment of Anthony M. Manning, Ph.D. to Board of Directors PR Newswire
24.03.17 - PR Newswire
Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll Holdings plc, Momenta Pharmaceuticals, Inc., Omnicom Group Inc., Perrigo Company plc, Santander Con
Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll Holdings plc, Momenta Pharmaceuticals, Inc., Omnicom Group Inc., Perrigo Company ...
07.03.17 - PR Newswire
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving the Board of Momenta Pharmaceuticals, Inc. -- MNTA
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving the Board of Momenta Pharmaceuticals, Inc. -- MNTA PR Newswire
22.02.17 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Momenta Pharmaceuticals, Inc. (MNTA)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Momenta Pharmaceuticals, Inc. (MNTA) PR Newswire
02.11.16 - PR Newswire
Momenta and Mylan Initiate Phase 1 Clinical Trial for M834, a Proposed Biosimilar of ORENCIA® (abatacept)
Momenta and Mylan Initiate Phase 1 Clinical Trial for M834, a Proposed Biosimilar of ORENCIA® (abatacept) -- Advancement of M834 to clinical-​stage development represents ...
08.01.16 - PR Newswire
Mylan Announces Worldwide Collaboration with Momenta to Jointly Develop and Commercialize Six Biosimilar Products
Mylan Announces Worldwide Collaboration with Momenta to Jointly Develop and Commercialize Six Biosimilar Products Partnership Builds on Successful Existing Collaboration ...
09.11.11 - Aktiencheck
Momenta Pharmaceuticals "buy" - Canaccord Genuity
Ritu Baral, Analyst von Canaccord Genuity, stuft die Aktie von Momenta Pharmaceuticals unverändert mit dem Rating "buy" ein. Das Kursziel werde bei 22 USD gesehen. (Analyse ...

Newssuche

Videos

newspaper
06.06.24 +3,57%
Technical Trading: Erdgas nach Rücksetzer Long
Erdgas Long Typ: Turbo Open End WKN: VM6KAH Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »